Latest Health News

TUESDAY, June 8, 2021 (HealthDay News) -- Your teens' route to a healthy or unhealthy weight may be in their hands -- literally.New research out of South Korea shows that teens who spend too much time on their smartphones are also more prone to eating habits that increase their odds for obesity.One nutritionist who helps treat obesity in the young wasn't surprised by the findings."Spending hours on end on your phone — or any blue-light screen — can disrupt our sleeping patterns, and less snooze can affect our appetite-stimulating hormones, causing hyperphagia [overeating]," explained registered dietitian Sharon Zarabi, who wasn't involved in the new research."Ever wonder why you're craving carbs when you haven't had a full night's rest?" said Zarabi, who directs the Katz Institute...

TUESDAY, June 8, 2021 (HealthDay News) – If you're like most American adults, it might be time to reach for a piece of fruit, a plate of vegetables or a bowl of whole grains.Only 7% of adults get enough fiber, a type of carbohydrate that passes through the body undigested and supports not only regular bowel movements, but also offers important health benefits. Too little fiber is associated with a higher risk of both heart disease and diabetes.An analysis of data from more than 14,600 U.S. adults who participated in a national health survey between 2013 and 2018 showed that 9% of women and 5% of men were getting the recommended daily amount of fiber."These findings should remind people to choose fiber-rich foods like whole grains, fruits and vegetables to reduce their risk for heart...

TUESDAY, June 8, 2021 (HealthDay News) -- New research suggests that many people who've undergone an organ transplant do not get an immune response from COVID-19 vaccines that's strong enough to ward off a "breakthrough" infection.In a new review of 14 such cases, these breakthrough COVID-19 infections occurred in 10 recipients of new kidneys, two liver recipients, one lung recipient and one heart recipient, said a research team working in New York City.Eight of them had completed the Pfizer COVID-19 two-dose vaccine series, five had completed the Moderna two-dose series and one had gotten the Johnson & Johnson single-dose vaccine, according to the team from NYU Langone. "We need additional studies to determine why these breakthrough cases may be occurring and how to prevent them, but...

MONDAY, June 7, 2021 (HealthDay News) -- The U.S. Food and Drug Administration has approved the first new drug to treat Alzheimer's disease in nearly two decades, in a controversial decision that left the agency defending its reputation and its science.Aduhelm (aducanumab) treats Alzheimer's by clearing out amyloid beta, a sticky protein known to form plaques in the brains of early-stage patients.It is the first approved Alzheimer's drug meant to attack one of the suspected root causes of the degenerative brain disease. All other drugs on the market manage symptoms, but cannot slow the disease's progression.The FDA approved Aduhelm under its "Accelerated Approval" pathway, which does not require conclusive proof that a drug provides a clinical benefit, Dr. Patrizia Cavazzoni, director...